
Vancouver, British Columbia, Sep 26, 2018 - (ACN Newswire) - PreveCeutical Medical Inc. ("PreveCeutical") (CSE: PREV, OTCQB: PRVCF, FSE: 18H), and Asterion Cannabis Inc. ("Asterion") announce that they have entered into a development and joint venture agreement (the "Development Agreement") to form a joint venture ("Joint Venture") to develop a...
Read more: PreveCeutical Enters into Development Agreement with Asterion Cannabis Inc. to Develop Medicinal...